Showing results (81-90 of 103) with videos related to
Sort By:
Pageof 11
Bone Marrow Transplantation|October 1, 1994
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failureJ Nemunaitis, M Ross, B Meisenberg, et al.American Journal of Clinical Oncology|December 18, 1998
The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancerJ Vredenburgh, R Fishman, D Coniglio, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trialW P Peters, J P Eder, W D Henner, et al.Journal of the National Cancer Institute|July 7, 1993
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanomaB R Meisenberg, M Ross, J J Vredenburgh, et al.Bone Marrow Transplantation|March 7, 1998
Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liverD C Fisher, J J Vredenburgh, W P Petros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancerW P Peters, M Ross, J J Vredenburgh, et al.Cancer Research|December 1, 1987
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumorsW P Peters, W D Henner, L B Grochow, et al.Bone Marrow Transplantation|June 1, 2000
Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancerJ L Klein, P M Rey, R D Dansey, et al.Bone Marrow Transplantation|February 1, 1991
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantationE J Shpall, R C Bast, W T Joines, et al.Pageof 11